US Food and Drug Administration
Pfizers Effexor XR and Greenstone brands
FDA posts press releases and other notices of recalls and market withdrawals from the firms involved as a service to consumers, the media, and other interested parties.
Trending on the Topix Network
Wed Mar 05, 2014
MDC Partners Shuffles Media Units, Spins Off 'Assembly'
It has also rolled two prior agency acquisitions, TargetCast and RJ Palmer, into a new, 250-person-strong media agency called Assembly, which will function as a unit within MDC Media Partners.
Tue Mar 04, 2014
How Rare Disease Know-how Can Shape Big Pharma Clinical Trials
When Andy Lee joined Genzyme from Pfizer, the differences between the companies were staring him in the face.
Mon Mar 03, 2014
Stopping criminal access to APIs must not block generics, says expert
Criminal access to APIs must be cut off in a way that does not infringe generics companies' right to buy chemicals, a top US prosecutor told In-Pharmatechnologist.com.
Week in Review: To Stage Hong Kong IPO
More detailsa . Stock Symbols: Help employers find you! Check out all the jobs and post your resume .
Pfizer aims to sell over-the-counter version of Lipitor
Pfizer recently started a 1,200-patient clinical trial to test if consumers taking a nonprescription Lipitor get their own blood tests to see if the medicine is improving their cholesterol and then make the right decisions based on the results.
Apple's Missteps Could Be BlackBerry's Turnaround
For a long period of time, BlackBerry was the de facto choice for businesses looking for a secure mobile device.
Sun Mar 02, 2014
The Washington Post
Gene Mutations Found in Type 2 Diabetes Seen as Drugmaker Target
Scientists have uncovered gene mutations that slash the risk of Type 2 diabetes regardless of age and weight, offering drugmakers a novel target to combat one of the major health threats confronting the modern world.
Wall St. Cheat Sheet
Will Pfizer Bounce Back From Last Year's Levoxyl Shortage?
Pfizer Inc. will again be shipping a thyroid drug that was in short supply last year.
Fri Feb 28, 2014
The Jersey Journal
Data center under construction at former Pfizer lab in South Brunswick
Steel ORCA will open a 300,000 square-foot data center on Ridge Road at the site of a former Pfizer laboratory.
DIA Announces Internationally Acclaimed Leaders as Co-Chairs of Milestone Meeting
DIA today announced that two worldwide leaders in the pharmaceutical and medical product development will co-chair the DIA 2014 50th Annual Meeting June 15-19 at the San Diego Convention Center.
Tue Feb 25, 2014
Q1 Productions Hosting 3rd Annual Regulatory Writing and Submission Conference
For the third consecutive year, Q1 Productions will be hosting the Regulatory Writing and Submission Conference on May 8-9, 2014 in Alexandria, Virginia, offering medical and regulatory writers and submissions specialists an opportunity to meet with the industry's biggest names and receive the most relevant information pertaining to today's ... (more)
Drug Roundup - February 25, 2014
There have been several noteworthy developments in the drug space recently, which will likely have a material impact on the companies in this sector and the markets they serve.
Essex Medipharma To Distribute Pfizer Inc. Glaucoma Eye Drops In China
XalatanA and XalacomA eye drops both treat the high intraocular fluid pressure associated with glaucoma.
Megamerger brings Actavis into R&D race
Generic drug giant Actavis is to buy speciality pharmaceutical firm Forest Labs in a deal worth about $25 billion , bringing Actavis into the drug discovery business.
Pfizer Given "Buy" Rating at TheStreet
's stock had its "buy" rating reiterated by equities researchers at TheStreet in a research report issued on Tuesday, ARN reports.
Pfizer pleased with pneumonia vaccine trial for older adults
Pfizer Inc. in New York said the trial of its pneumonia immunization in adults age 65 and older against bacterial pneumonia achieved its goals.
Customer Interaction Solutions
OncoSec Medical to Present at 24th Annual Wall Street Analyst Forum Institutional Investor Conference
OncoSec Medical Inc. , a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy to treat solid tumors, today announced that Punit Dhillon, President and CEO, will present a corporate overview of the company at the 24th Annual Wall Street Analyst Forum Institutional Investor Conference at the University Club in New York, New York ... (more)
Mon Feb 24, 2014
GEA Pharma Systems Release: Continuous Pharmaceutical Processing: Anytime, Anywhere, Interphex
PCMM comprises a system that integrates small footprint, continuous processing equipment, smart control systems and PODs to process API powders and inactive ingredients through to bulk tablets.
Pfizer Announces FDA Approval to Include Radiographic Data on...
Pfizer Inc. announced today that the U.S. Food and Drug Administration has approved a supplemental New Drug Application to update the current label of XELJANZ 5 mg tablets to include radiographic data from two Phase 3 studies, ORAL Scan and ORAL Start .